Skip to content
healthcare.dev

Medroxyprogesterone Acetate

NDC 0548-5701, Medroxyprogesterone acetate, injection, suspension, extended release, from Amphastar Pharmaceuticals, Inc..

Product NDC
0548-5701
Status
Listed
Labeler
Amphastar Pharmaceuticals, Inc.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077334
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5701 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEDROXYPROGESTERONE ACETATE150 mg/mL

Pharmacologic classes

Progesterone Congeners [CS]; Progestin [EPC]

Package NDCNDC-11Package
0548-5701-00005485701001 SYRINGE in 1 CARTON (0548-5701-00) / 1 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fda1aa8a-5739-482a-b4f6-9741ef4d9977
  • NADAC price for package 00548570100

    GET /v1/drugs/nadac/00548570100

Use it

Look up 0548-5701 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0548-5701 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0548-5701. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.